A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/brain-nervous.jpg)
Details
Age
Child to Adult
Locations
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
![Photograph of Nitish Harid](https://som.ucdenver.edu/FIMS/Content/faculty/35611/CU-Doctors-35611.jpg)
Nitish Harid
Study ID
Protocol Number: 23-0395
More information available at ClinicalTrials.gov: NCT05614063
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers